Correlation Between Achieve Life and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Achieve Life and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achieve Life and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achieve Life Sciences and Akari Therapeutics PLC, you can compare the effects of market volatilities on Achieve Life and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achieve Life with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achieve Life and Akari Therapeutics.
Diversification Opportunities for Achieve Life and Akari Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Achieve and Akari is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Achieve Life Sciences and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Achieve Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achieve Life Sciences are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Achieve Life i.e., Achieve Life and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Achieve Life and Akari Therapeutics
Given the investment horizon of 90 days Achieve Life Sciences is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Achieve Life Sciences is 2.44 times less risky than Akari Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 169.00 in Akari Therapeutics PLC on November 28, 2024 and sell it today you would lose (78.00) from holding Akari Therapeutics PLC or give up 46.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achieve Life Sciences vs. Akari Therapeutics PLC
Performance |
| Timeline |
| Achieve Life Sciences |
| Akari Therapeutics PLC |
Achieve Life and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achieve Life and Akari Therapeutics
The main advantage of trading using opposite Achieve Life and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achieve Life position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| Achieve Life vs. Apellis Pharmaceuticals | Achieve Life vs. Iteos Therapeutics | Achieve Life vs. Tscan Therapeutics | Achieve Life vs. Day One Biopharmaceuticals |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |